S&P 500   5,134.16 (-0.06%)
DOW   38,997.55 (-0.23%)
QQQ   445.22 (-0.09%)
AAPL   175.37 (-2.39%)
MSFT   415.20 (-0.07%)
META   499.02 (-0.65%)
GOOGL   133.58 (-2.60%)
AMZN   178.02 (-0.11%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.41 (-6.40%)
AMD   208.42 (+2.85%)
BABA   72.02 (-3.48%)
T   16.80 (-1.06%)
F   12.83 (+3.05%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   114.10 (+1.92%)
AMC   4.35 (-0.23%)
PFE   25.79 (-3.01%)
PYPL   60.12 (-0.69%)
XOM   104.53 (-1.24%)
S&P 500   5,134.16 (-0.06%)
DOW   38,997.55 (-0.23%)
QQQ   445.22 (-0.09%)
AAPL   175.37 (-2.39%)
MSFT   415.20 (-0.07%)
META   499.02 (-0.65%)
GOOGL   133.58 (-2.60%)
AMZN   178.02 (-0.11%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.41 (-6.40%)
AMD   208.42 (+2.85%)
BABA   72.02 (-3.48%)
T   16.80 (-1.06%)
F   12.83 (+3.05%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   114.10 (+1.92%)
AMC   4.35 (-0.23%)
PFE   25.79 (-3.01%)
PYPL   60.12 (-0.69%)
XOM   104.53 (-1.24%)
S&P 500   5,134.16 (-0.06%)
DOW   38,997.55 (-0.23%)
QQQ   445.22 (-0.09%)
AAPL   175.37 (-2.39%)
MSFT   415.20 (-0.07%)
META   499.02 (-0.65%)
GOOGL   133.58 (-2.60%)
AMZN   178.02 (-0.11%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.41 (-6.40%)
AMD   208.42 (+2.85%)
BABA   72.02 (-3.48%)
T   16.80 (-1.06%)
F   12.83 (+3.05%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   114.10 (+1.92%)
AMC   4.35 (-0.23%)
PFE   25.79 (-3.01%)
PYPL   60.12 (-0.69%)
XOM   104.53 (-1.24%)
S&P 500   5,134.16 (-0.06%)
DOW   38,997.55 (-0.23%)
QQQ   445.22 (-0.09%)
AAPL   175.37 (-2.39%)
MSFT   415.20 (-0.07%)
META   499.02 (-0.65%)
GOOGL   133.58 (-2.60%)
AMZN   178.02 (-0.11%)
TSLA   189.13 (-6.67%)
NVDA   864.46 (+5.06%)
NIO   5.41 (-6.40%)
AMD   208.42 (+2.85%)
BABA   72.02 (-3.48%)
T   16.80 (-1.06%)
F   12.83 (+3.05%)
MU   96.73 (+1.66%)
CGC   3.05 (-4.98%)
GE   160.91 (+1.42%)
DIS   114.10 (+1.92%)
AMC   4.35 (-0.23%)
PFE   25.79 (-3.01%)
PYPL   60.12 (-0.69%)
XOM   104.53 (-1.24%)

Sagimet Biosciences (SGMT) SEC Filings & 10K Form

$6.35
+0.33 (+5.48%)
(As of 03:33 PM ET)

Recent Sagimet Biosciences SEC Filings

DateFilerForm TypeView
02/14/2024
5:10 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/14/2024
5:20 AM
KPCB PANDEMIC & BIO DEFENSE FUND LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/09/2024
8:49 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G/A
02/05/2024
3:34 PM
Point72 Asset Management, L.P. (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
02/02/2024
3:36 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2024
3:55 PM
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:56 PM
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:57 PM
BASKETT FOREST (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
3:59 PM
KERINS PATRICK J (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2024
4:00 PM
Sagimet Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
3:05 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
01/24/2024
5:08 AM
Sagimet Biosciences (Filer)
Form S-1/A
01/24/2024
5:10 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2024
4:31 PM
Sagimet Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
01/22/2024
7:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/29/2023
3:16 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:23 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:25 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:15 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2023
3:21 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2023
3:22 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
8:59 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2023
7:40 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
7:31 AM
Sagimet Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2023
7:00 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2023
3:32 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2023
7:23 AM
FMR LLC (Filed by)
Sagimet Biosciences (Subject)
Form SC 13G
09/08/2023
3:15 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
7:14 AM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/20/2023
5:56 PM
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Sagimet Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:20 PM
KPCB PANDEMIC & BIO DEFENSE FUND LLC (Reporting)
KPCB PBD Associates, LLC (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:15 PM
GRAMMER ELIZABETH A (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:15 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:16 PM
Hom Dennis (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:17 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:17 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:17 PM
Parsey Merdad (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:18 PM
Rimac Anthony M (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:18 PM
Rodgers Richard J (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:19 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:19 PM
Sagimet Biosciences (Issuer)
Wu Jinzi Jason (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2023
3:20 PM
Sagimet Biosciences (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2023
3:05 PM
Sagimet Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/17/2023
6:00 AM
Sagimet Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/13/2023
11:15 PM
Sagimet Biosciences (Filer)
Form EFFECT
07/13/2023
8:38 PM
BASKETT FOREST (Reporting)
KERINS PATRICK J (Reporting)
NEA 13 GP, Ltd (Reporting)
NEA Partners 13, Limited Partnership (Reporting)
NEW ENTERPRISE ASSOCIATES 13 LP (Reporting)
Sagimet Biosciences (Issuer)
SANDELL SCOTT D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:25 PM
KPCB PANDEMIC & BIO DEFENSE FUND LLC (Reporting)
KPCB PBD Associates, LLC (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:10 PM
Sagimet Biosciences (Issuer)
Wu Jinzi Jason (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:11 PM
Sagimet Biosciences (Issuer)
SEIDENBERG BETH C (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
7:59 PM
GRAMMER ELIZABETH A (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:00 PM
Hom Dennis (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:01 PM
Happel David (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:03 PM
Kemble George (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:04 PM
Martins Eduardo Bruno (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:05 PM
Parsey Merdad (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:06 PM
Rimac Anthony M (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:07 PM
Rodgers Richard J (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
8:08 PM
Rozek Elizabeth (Reporting)
Sagimet Biosciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
07/13/2023
6:43 PM
Sagimet Biosciences (Filer)
Form S-1MEF
07/13/2023
1:28 PM
Sagimet Biosciences (Filer)
Form CERT
07/11/2023
3:04 PM
Sagimet Biosciences (Filer)
Form 8-A12B
07/10/2023
5:04 AM
Sagimet Biosciences (Filer)
Form S-1/A
07/03/2023
3:08 PM
Sagimet Biosciences (Filer)
Form S-1/A
06/23/2023
4:03 PM
Sagimet Biosciences (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:SGMT) was last updated on 3/4/2024 by MarketBeat.com Staff